Ticker Details
Pulmonx Corporation
IPO Date:	October 1, 2020
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$62.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 3.07%
Avg Daily Range (30 D):	$0.05 | 2.83%
Avg Daily Range (90 D):	$0.08 | 4.11%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	1.89M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	115
Avg Trade Size (Sh.) (90 D):	219

Institutional Trades
Total Institutional Trades:	993
Avg Institutional Trade:	$1.66M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$.88M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.62M
Avg Closing Trade (30 D):	$1.01M
Avg Closing Trade (90 D):	$1.01M
Avg Closing Volume:	66.97K

News

Jun 24, 2024 @ 12:16 PM 5 Medical Info Systems Stock to Buy for a Stable P... Source: Nalak Das

May 22, 2024 @ 1:55 PM How Much Upside is Left in Pulmonx (LUNG)? Wall St... Source: Zacks Equity Research

May 10, 2024 @ 12:29 PM 5 Medical Info Systems Stocks to Buy for Stable Re... Source: Nalak Das

May 6, 2024 @ 9:03 PM Pulmonx Announces Inducement Grants under Nasdaq L... Source: Pulmonx Corporation

May 6, 2024 @ 1:55 PM Wall Street Analysts See a 56.11% Upside in Pulmon... Source: Zacks Equity Research

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.34	$-.38	$-.36
Diluted EPS	$-.34	$-.38	$-.36
Revenue	$21.5M	$23.86M	$22.54M
Gross Profit	$16.05M	$17.2M	$16.34M
Net Income / Loss	$-13.96M	$-15.17M	$-14.45M
Operating Income / Loss	$-14.39M	$-14.8M	$-14.56M
Cost of Revenue	$5.45M	$6.66M	$6.2M
Net Cash Flow	$1.09M	$.91M	$3.65M
PE Ratio